Management of isolated soleal and gastrocnemius vein thrombosis.
Summary of "Management of isolated soleal and gastrocnemius vein thrombosis."
The ideal treatment for hospitalized patients with isolated gastrocnemius and/or soleal venous thrombosis is unclear. Recommendations range from watchful waiting to full-dose anticoagulation. This study examines the effectiveness of practice patterns at a single institution as measured by progression of thrombus.
All consecutive inpatients with a duplex scan diagnosis of isolated gastrocnemius and/or soleal vein clot (no other thrombotic segments were identified) and where two consecutive duplex studies (Intersocietal Commission for the Accreditation of Vascular Laboratories laboratory) were available for review were included. Two study groups were identified. TX group included patients who received anticoagulation treatment (heparin [fractionated or unfractionated], heparin substitutes, or warfarin) and the NoTX group included those who did not receive anticoagulant. Demographic, risk factors, comorbidities, length of hospital and intensive care unit stay, ambulatory status, and underlying hypercoagulable states were recorded. Thrombus progression rate in the two groups was compared using the chi(2) test. A multivariate logistic regression model was used to examine the effect of anticoagulation treatment as well as the above demographic and clinical factors on the risk of progression.
A total of 141 patients were included in the study, 76 of whom (54%) received anticoagulation. Forty-three patients (30%) had progression of their venous thrombosis: 33% (25/76) in the TX group and 28% (18/65) in the NoTX group (P = .50, by chi(2) test). Results from multivariate logistic regression showed that treatment had no significant impact on outcome (Odds ratio = 1.28, 95% confidence interval: 0.55-3.01; P = .57]. Patients with end-stage renal disease (6%), or stroke (13%) had significantly higher risk of progression (P < .05). None of the other clinical or demographic factors were significantly associated with the risk of progression.
The results speak to the lack of efficacy of anticoagulation in the management of gastrocnemius and/or soleal vein thrombosis in the hospitalized patient. When measured by thrombus progression, treating these patients without anticoagulation appears to be equally efficacious as subjecting patients to anticoagulant therapy. A prospective, randomized clinical trial will be an important step in fully addressing this clinical dilemma.
Overlook Hospital and the Cardiovascular Care Group, Summit, NJ and Westfield, NJ.
This article was published in the following journal.
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20630686
- DOI: http://dx.doi.org/10.1016/j.jvs.2010.05.102
Medical and Biotech [MESH] Definitions
Upper Extremity Deep Vein Thrombosis
DEEP VEIN THROMBOSIS of an upper extremity vein (e.g., AXILLARY VEIN; SUBCLAVIAN VEIN; and JUGULAR VEINS). It is associated with mechanical factors (Upper Extremity Deep Vein Thrombosis, Primary) secondary to other anatomic factors (Upper Extremity Deep Vein Thrombosis, Secondary). Symptoms may include sudden onset of pain, warmth, redness, blueness, and swelling in the arm.
A short thick vein formed by union of the superior mesenteric vein and the splenic vein.
The formation or presence of a blood clot (THROMBUS) within a vein.
The continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the brachiocephalic vein.
The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.
Acute pancreatitis can result in many vascular complications in both artery and vein. Venous complication usually occurs as a form of splenic or portal vein thrombosis, and also can simultaneously occ...
BACKGROUND: Treatment of isolated calf muscle vein thrombosis (ICMVT) is controversial. There is no data from prospective, controlled studies. Objective of this article was to compare the efficacy and...
This is a safety and cost comparison study with an analysis of budgetary impact of ambulatory management of patients with cancer and deep vein thrombosis (DVT) compared with hospital management.
The prevalence of isolated calf deep vein thrombosis (DVT) in the community setting is relatively unexplored. Confusion remains with regards to its management and contemporary natural history. The pur...
OBJECTIVE: To describe a case of superior mesenteric vein thrombosis associated with IVF. DESIGN: Case report. SETTING: University teaching hospital. PATIENT(S): A 33-year-old female developed progres...
CACTUS is a randomized, placebo-controlled, double-blind study comparing anticoagulation and elastic contention versus contention alone in symptomatic calf vein thrombosis.
The CACTUS study is a 6-week evaluation of anticoagulant treatment effect on reducing infrapopliteal deep vein thrombosis (DVT) extension to proximal veins. Its aim is to demonstrate if th...
ABSTRACT Background The optimal duration of oral anticoagulant treatment in patients with idiopathic venous thromboembolism is still uncertain . The present study addressed the possible ro...
The objective of this NIS is to assess in a real-life setting, usage patterns and associated outcomes in the management (healthcare resource utilisation and associated costs) of patients w...
The duration of anticoagulant treatment in cancer patients with Deep Vein Thrombosis (DVT) of the lower limbs is still uncertain. The present study addresses the possible role of the Resid...